| Synonyms: | |
| Status: | Approved (2010) |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | L01XX41 |
| UNII: | LR24G6354G |
| InChI Key | UFNVPOGXISZXJD-JBQZKEIOSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C40H59NO11 |
| Molecular Weight | 729.91 |
| AlogP | 3.44 |
| Hydrogen Bond Acceptor | 12.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 146.39 |
| Molecular species | BASE |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 52.0 |
| Primary Target | |
|---|---|
| tubulin beta class I |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Neoplasms | 4 | D009369 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 3 | D002289 | ClinicalTrials |
| Breast Neoplasms | 3 | D001943 | ClinicalTrials |
| Breast Neoplasms | 3 | D001943 | ClinicalTrials |
| Inflammatory Breast Neoplasms | 2 | D058922 | ClinicalTrials |
| Hereditary Breast and Ovarian Cancer Syndrome | 2 | D061325 | ClinicalTrials |
| Sarcoma | 2 | D012509 | ClinicalTrials |
| Hemangiosarcoma | 2 | D006394 | ClinicalTrials |
| Hemangioendothelioma, Epithelioid | 2 | D018323 | ClinicalTrials |
| Solitary Fibrous Tumors | 2 | D054364 | ClinicalTrials |
| Melanoma | 1 | D008545 | ClinicalTrials |
| Carcinoma, Renal Cell | 1 | D002292 | ClinicalTrials |
| Ovarian Neoplasms | 1 | D010051 | ClinicalTrials |
| Melanoma | 1 | D008545 | ClinicalTrials |
| Fallopian Tube Neoplasms | 1 | D005185 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 253128-41-5 |
| ChEBI | 63587 |
| ChEMBL | CHEMBL1683590 |
| DrugBank | DB08871 |
| DrugCentral | 4171 |
| FDA SRS | LR24G6354G |
| Guide to Pharmacology | 6813 |
| PDB | 6K9 |
| PubChem | 11354606 |
| SureChEMBL | SCHEMBL15783821 |
| ZINC | ZINC000169344691 |